SynthesisBMJ open2014
Systematic review on the primary and secondary reporting of the prevalence of ghostwriting in the medical literature.
Synthesis in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- No room for ambiguity: The concepts of appropriate and inappropriate authorship in scientific publications.Indian journal of ophthalmology · 2021Article
- Authorship: from credit to accountability. Reflections from the Editors' Network.Clinical research in cardiology : official journal of the German Cardiac Society · 2019Review
- Authorship: from credit to accountability : Reflections from the Editors' Network.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2019Article
- Authorship: From Credit to Accountability Reflections From the Editors´ Network.Anatolian journal of cardiology · 2019Article
- Article
- Ghostwriters in the scientific world.The Pan African medical journal · 2018Article
- Professional medical writing support and the reporting quality of randomized controlled trial abstracts among high-impact general medical journals.F1000Research · 2017Article
- The relationship between the physician and pharmaceutical industry: background ethics and regulation proposals.Croatian medical journal · 2016Article
- Who is innocent in authorship misconduct?Dong wu xue yan jiu = Zoological research · 2016Article
- Social-cognitive barriers to ethical authorship.Frontiers in psychology · 2015Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGhostwriting of industry-sponsored articles is unethical and is perceived to be common practice.
objectiveTo systematically review how evidence for the prevalence of ghostwriting is reported in the medical literature. DATA SOURCES: MEDLINE via PubMed 1966+, EMBASE 1966+, The Cochrane Library 1988+, Medical Writing 1998+, The American Medical Writers Association (AMWA) Journal 1986+, Council of Science Editors Annual Meetings 2007+, and the Peer Review Congress 1994+ were searched electronically (23 May 2013) using the search terms ghostwrit*, ghostauthor*, ghost AND writ*, ghost AND author*. ELIGIBILITY CRITERIA: All publication types were considered; only publications reporting a numerical estimate of possible ghostwriting prevalence were included. DATA EXTRACTION: Two independent reviewers screened the publications; discrepancies were resolved by consensus. Data to be collected included a numerical estimate of the prevalence of possible ghostwriting (primary outcome measure), definitions of ghostwriting reported, source of the reported prevalence, publication type and year, study design and sample population.
resultsOf the 848 publications retrieved and screened for eligibility, 48 reported numerical estimates for the prevalence of possible ghostwriting. Sixteen primary publications reported findings from cross-sectional surveys or descriptive analyses of published articles; 32 secondary publications cited published or unpublished evidence. Estimates on the prevalence of possible ghostwriting in primary and secondary publications varied markedly. Primary estimates were not suitable for meta-analysis because of the various definitions of ghostwriting used, study designs and types of populations or samples. Secondary estimates were not always reported or cited correctly or appropriately.
conclusionsEvidence for the prevalence of ghostwriting in the medical literature is limited and can be outdated, misleading or mistaken. Researchers should not inflate estimates using non-standard definitions of ghostwriting nor conflate ghostwriting with other unethical authorship practices. Editors and peer reviewers should not accept articles that incorrectly cite or interpret primary publications that report the prevalence of ghostwriting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.